2 recruiting, 1 active not recruiting, 1 terminated, 1 unknown. 2 Phase 1, 1 Early Phase 1, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Malignant Abdominal Neoplasm: new trials by email Literature Review of Malignant Abdominal Neoplasm trials Research Report on Malignant Abdominal Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors Biospecimen Collection, Near Infrared Imaging, Pafolacianine Sodium - Childhood Malignant Solid Neoplasm, Childhood Malignant Thoracic Neoplasm | Phase 3 | Recruiting | Mayo Clinic | 20 | 2025-04-15 | 2026-04-01 |
| Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel - Advanced Breast Carcinoma, Advanced Endometrial Carcinoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 43 | 2022-04-29 | 2026-07-16 |
| Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery Behavioral Intervention, Best Practice, Questionnaire Administration - Malignant Abdominal Neoplasm, Malignant Head and Neck Neoplasm | Not applicable | Unknown | Lucid Lane, Inc | 272 | 2021-02-23 | 2022-05-10 |
| Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients Cisplatin, Cytoreductive Surgery, Doxorubicin - Malignant Abdominal Neoplasm, Malignant Pelvic Neoplasm | Early Phase 1 | Terminated | Mayo Clinic | 2 | 2019-11-08 | 2025-02-20 |
| Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery Eribulin Mesylate, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis - Liposarcoma, Malignant Abdominal Neoplasm | Phase 1 | Active not recruiting | OHSU Knight Cancer Institute | 15 | 2018-03-19 | 2026-04-08 |
Fallopian Tube Neoplasms (2) · Head and Neck Neoplasms (2) · Liposarcoma (2) · Ovarian Neoplasms (2) · Pelvic Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Colonic Neoplasms (1) · Desmoplastic Small Round Cell Tumor (1) · Endometrial Neoplasms (1) · Mesothelioma, Malignant (1) · Rectal Neoplasms (1) · Rhabdomyosarcoma (1) · Sarcoma (1)
Neoplasms (5) · Neoplasms by Site (4) · Neoplasms by Histologic Type (3) · Adnexal Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Fallopian Tube Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Gonadal Disorders (2)
Specimen Handling (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · 130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Behavior Therapy (1) · Cisplatin (1) · Cytoreduction Surgical Procedures (1) · Doxorubicin (1) · Hyperthermic Intraperitoneal Chemotherapy (1) · Magnetic Resonance Spectroscopy (1) · Pafolacianine (1) · Platinum (1) · Practice Guidelines as Topic (1) · Radiotherapy, Intensity-Modulated (1) · Standard of Care (1)
Mayo Clinic (2) · Lucid Lane, Inc (1) · M.D. Anderson Cancer Center (1) · OHSU Knight Cancer Institute (1)
United States (5)
Apostolia M Tsimberidou (1) · Lakshmi Koyyalagunta (1) · Lara E Davis (1) · Patricio C. Gargollo, M.D. (1) · Stephanie F. Polites, MD, MPH (1)